Share the Video:

Building the next generation of psychedelic care clinics

Daniel Kelly, Gregory Kearns, Payton Nyquvest

The long-term success and integration of psychedelic therapy into the North American healthcare system will depend on the ability of clinics to provide safe and responsible care to patients. Given the novelty of this treatment modality, as well as the importance of the environmental factors in therapeutic outcomes, this infrastructure must be planned with care. Come learn what new and existing clinics need to consider as they prepare to deliver psychedelic services.

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

Lessons from the first three years of psychedelic public companies

Psychedelic businesses have rapidly emerged on American and Canadian exchanges, creating a multibillion dollar market. Industry insiders discuss challenges and predictions for psychedelic public companies.

Patrick Trucchio, Florian Brand, George Tziras, Tim Chang

PS2023 Health Equity Policy and Advocacy Psychedelic Assisted Therapy Public Benefit Research and Science

Achieving market access and reimbursement for psychedelic therapy

Panel experts discuss insurance coverage requirements for wide accessibility of psychedelic therapy, addressing what payors will need to support the treatments.

Elliot Marseille, Dan Grossman, Sherry Rais, Leslie Nylund

PS2023 Harm Reduction Health Conditions Integration Psilocybin Psychedelic Assisted Therapy Research and Science

Pilot study of Psilocybin-Assisted Therapy in Hospice care (PATH): preliminary feasibility, safety and efficacy considerations

Clinicians and researchers discuss integrating psilocybin-assisted therapy into serious illness care models, presenting preliminary findings from a pilot study in hospice care for patients with terminal illness.

Yvan Beaussant, Roxanne Sholevar, Lisa Summer, Robin McKenna

PS2023 Integration Psychedelic Assisted Therapy Research and Science Resources for Therapists Social and Cultural Therapy Ethics

Becoming a Psychedelic Therapist

Discussion on essential components for becoming a successful psychedelic therapist, including education, training, and ongoing support. Addressing challenges, risks, and considerations for training future therapists to prevent issues like boundary

Genesee Herzberg

PS2023 Integration Psychedelic Assisted Therapy Psychedelic Science Research and Science Social and Cultural Spirituality

Judaism and Psychedelics

Panelists explore Judaism's historical, cultural, and contemporary views on psychedelics, examining their potential role in Jewish spirituality and healing practices through ritual, history, and mysticism. The conversation aims to deepen

Sam Shonkoff, Rabbi Tirzah Firestone, Madison Margolin

PS2023 Harm Reduction Integration Psilocybin Psychedelic Assisted Therapy Research and Science Resources for Therapists

Psychedelic-Assisted Training: Outcomes from a World-First Study

Psychedelic therapies re-emerge in clinical research, prompting exploration of therapist training methods and competencies. A study involving psilocybin support for therapists shows potential benefits for psychedelic therapy implementation.

Paul Liknaitzky

PS2023 Integration Psychedelic Assisted Therapy Psychedelic Science Research Research and Science

Sleep, Dreams, and Psychedelics

Psychedelics affect sleep and dreaming, with decreased overall sleep and delayed REM onset. Electrophysiological studies show similarities between psychedelic experiences and slow-wave sleep and REM sleep.

Sidarta Ribeiro

PS2023 Integration Psychedelic Assisted Therapy Psychedelic Science Research and Science Spirituality Therapy Ethics

Buddhism and Psychedelics

Panel explores interplay between psychedelics and Buddhist philosophy/practice, discussing potential for expanded awareness/self-discovery/liberation and presenting unique perspective on relationship between the two.

Daan Keiman, Kan Yan

PS2023 Ancestral Knowledge Integration Plant Medicine Psychedelic Assisted Therapy Psychedelic Science Research and Science

Reflections on a Lifetime with Psychedelics

Dr. Fadiman shares insights from personal psychedelic experiences and interactions with key pioneers, highlighting how psychedelics influence his Integrative Medicine philosophy and potential for global impact.

Andrew Weil

Building the next generation of psychedelic care clinics

Become a MAPS Member with a monthly donation

Related Videos